These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 144504)
21. Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. Mast AE; Higuchi DA; Huang ZF; Warshawsky I; Schwartz AL; Broze GJ Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):577-83. PubMed ID: 9359432 [TBL] [Abstract][Full Text] [Related]
22. The Kaposi's sarcoma-associated herpesvirus complement control protein (KCP) binds to heparin and cell surfaces via positively charged amino acids in CCP1-2. Mark L; Lee WH; Spiller OB; Villoutreix BO; Blom AM Mol Immunol; 2006 Apr; 43(10):1665-75. PubMed ID: 16442624 [TBL] [Abstract][Full Text] [Related]
23. Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate. Milz F; Harder A; Neuhaus P; Breitkreuz-Korff O; Walhorn V; Lübke T; Anselmetti D; Dierks T Biochim Biophys Acta; 2013 Nov; 1830(11):5287-98. PubMed ID: 23891937 [TBL] [Abstract][Full Text] [Related]
24. Interaction of heparan sulfate and its fractions with endothelial cells in culture. Tiozzo R; Cingi MR; Croce MA Int J Tissue React; 1993; 15(4):163-8. PubMed ID: 8188456 [TBL] [Abstract][Full Text] [Related]
25. Correlation between cell substrate attachment in vitro and cell surface heparan sulfate affinity for fibronectin and collagen. Stamatoglou SC; Keller JM J Cell Biol; 1983 Jun; 96(6):1820-3. PubMed ID: 6222058 [TBL] [Abstract][Full Text] [Related]
26. Chemistry of heparitin sulfate and heparin from normal tissues and from patients with Hunter syndrome. Nader HB; Cohen DM; Dietrich CP Biochim Biophys Acta; 1979 Jan; 582(1):33-43. PubMed ID: 153768 [TBL] [Abstract][Full Text] [Related]
27. Evidence that the axolemmal mitogen for cultured Schwann cells is a positively charged, heparan sulfate proteoglycan-bound, heparin-displaceable molecule. DeCoster MA; DeVries GH J Neurosci Res; 1989 Mar; 22(3):283-8. PubMed ID: 2523488 [TBL] [Abstract][Full Text] [Related]
28. Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival. Stevens RB; Wang YL; Kaji H; Lloveras J; Dalmasso A; Bach FH; Rubinstein P; Sutherland DE; Platt JL Transplant Proc; 1993 Feb; 25(1 Pt 1):382. PubMed ID: 8438344 [No Abstract] [Full Text] [Related]
29. Inhibition of three alphaherpesviruses (herpes simplex 1 and 2 and pseudorabies virus) by heparin, heparan and other sulfated polyelectrolytes. Ramos-Kuri M; Barron Romero BL; Aguilar-Setien A Arch Med Res; 1996; 27(1):43-8. PubMed ID: 8867366 [TBL] [Abstract][Full Text] [Related]
30. Cell surface glycosaminoglycans of rat rhabdomyosarcoma lines with different metastatic potentials and of non-malignant rat myoblasts. Redini F; Moczar E; Poupon MF Biochim Biophys Acta; 1986 Aug; 883(1):98-105. PubMed ID: 3089301 [TBL] [Abstract][Full Text] [Related]
31. Binding of interferon-gamma to heparan sulfate is restricted to the heparin-like domains and involves carboxylic--but not N-sulfated--groups. Lortat-Jacob H; Grimaud JA Biochim Biophys Acta; 1992 Sep; 1117(2):126-30. PubMed ID: 1525174 [TBL] [Abstract][Full Text] [Related]
32. Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface. Iozzo RV J Cell Biol; 1984 Aug; 99(2):403-17. PubMed ID: 6235235 [TBL] [Abstract][Full Text] [Related]
33. Interaction of Chlamydia trachomatis with mammalian cells is independent of host cell surface heparan sulfate glycosaminoglycans. Stephens RS; Poteralski JM; Olinger L Infect Immun; 2006 Mar; 74(3):1795-9. PubMed ID: 16495553 [TBL] [Abstract][Full Text] [Related]
34. Metabolism of sulfated glycosaminoglycans in rat hepatocytes. Synthesis of heparan sulfate and distribution into cellular and extracellular pools. Prinz R; Klein U; Sudhakaran PR; Sinn W; Ullrich K; von Figura K Biochim Biophys Acta; 1980 Jul; 630(3):402-13. PubMed ID: 6446940 [TBL] [Abstract][Full Text] [Related]
35. Heparan structure and the modulation of angiogenesis. Long WF; Williamson FB Med Hypotheses; 1984 Apr; 13(4):385-94. PubMed ID: 6203020 [TBL] [Abstract][Full Text] [Related]
36. Cell surface glycosaminoglycans of cell line MDCK derived from canine kidney. Takeuchi J; Sobue M; Shamoto M; Yoshida M; Sato E; Leighton J Cancer Res; 1977 May; 37(5):1507-12. PubMed ID: 558051 [TBL] [Abstract][Full Text] [Related]
37. Interactions of cellular glycosaminoglycans with plasma fibronectin and collagen. Stamatoglou SC; Keller JM Biochim Biophys Acta; 1982 Oct; 719(1):90-7. PubMed ID: 7171625 [TBL] [Abstract][Full Text] [Related]
38. Biology of cell surface heparan sulfate proteoglycans. Jalkanen M Med Biol; 1987; 65(1):41-7. PubMed ID: 2956468 [TBL] [Abstract][Full Text] [Related]
39. The malaria circumsporozoite protein: interaction of the conserved regions I and II-plus with heparin-like oligosaccharides in heparan sulfate. Ying P; Shakibaei M; Patankar MS; Clavijo P; Beavis RC; Clark GF; Frevert U Exp Parasitol; 1997 Feb; 85(2):168-82. PubMed ID: 9030667 [TBL] [Abstract][Full Text] [Related]